Allergen stimulation induces simultaneous production of type 2 helper T cells and regulatory cytokines in patients with pollen allergy

Journal of Investigational Allergology and Clinical Immunology

Volumn 23, Issue 1, 2013, Pages 54-55

  Urra, J M ^a   Feo Brito, F ^a   Carrasco, P ^a   De la Roca, F ^a   Zamorano, J ^b  

^a HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^b HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

Author keywords

Foxp3; IL 4; Pollen allergy; TGF ; Treg

Indexed keywords

ASPARTIC ACID; AZITHROMYCIN; CD40 LIGAND; COTRIMOXAZOLE; GENOMIC DNA; GLYCINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AMINO ACID SUBSTITUTION; ANOREXIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CD40 LIGAND GENE; CHILD; CODON; DIARRHEA; EOSINOPHILIA; FAILURE TO THRIVE; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPER IGM SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; IRAN; LEUKOCYTOSIS; LUNG INFILTRATE; MALE; NEUTROPENIA; NEUTROPHIL COUNT; NONSENSE MUTATION; OTITIS MEDIA; PNEUMOCYSTIS JIROVECI; PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; THORAX RADIOGRAPHY;

ADULT; ALLERGENS; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TH2 CELLS; YOUNG ADULT;

EID: 84874385805     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, Kegel C, Disch R, Schmidt-Weber CB, Blaser K, Akdis CA. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004;199:1567-75.
2. Walker C, Virchow JC Jr, Bruijnzeel PL, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol. 1991;146:1829-35.
3. Bellinghausen I, Konig B, Bottcher I, Knop J, Saloga J. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction. Clin Exp Allergy. 2006;36:1546-55.
4. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994;265:1237-40.
5. Fontenot JD, Gavin MA, Rudensky AY. FOXP3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol. 2003;4:330-6.
6. Van Overtvelt L, Wambre E, Maillère B, von Hofe E, Louise A, Balazuc AM, Bohle B, Ebo D, Leboulaire C, Garcia G, Moingeon P. Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol. 2008;180:4514-22.
7. Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, Rudensky AY, Weaver CT. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat Immunol. 2007;9:931-41.
8. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, Carr VA, Robinson DS. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 2004;363:608-15.